BDX insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Michael Feld EVP, Chief Revenue Officer	76	$183.70	n/a	n/a	Sep 28, 2026	Sep 29, 2026

What stands out

Selling picked up in the last 90 days: officers and directors sold 6.9K shares, against an average of 3K per 90 days earlier in the period. Most of it was Thomas Polen Jr. (4.2K shares in the last 90 days) and Roland Goette (2.4K shares in the last 90 days); 65% of these sales were under disclosed plans.Thomas Polen Jr.: largest recent sale, Aug 13, 2026 · Roland Goette: largest recent sale, Aug 11, 2026

Bertram Scott sold 1.2K shares (3.2% of starting holdings), but 1.9K more vested, so the stake grew (from 36K to 37K).Largest sale, Feb 18, 2026

Percentages cover 15 of 28 officers and directors. 13 are left out

Left out: Thomas Polen Jr., Roland Goette, Shana Neal, Bilal Muhsin, Michael Feld, Carrie Byington, Michael Garrison, Vitor Roque, Pamela Spikner and Robert Huffines (holdings couldn't be fully reconciled); Jacqueline Wright, Lanesha Minnix and Peter Menziuso (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

SoldRest of starting stake

Thomas Polen Jr.

Chairman, CEO and President, Director

Sold $1.2M (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$1.2MDisclosed plan

Michael Garrison

EVP & Pres Med.Essntl&BioPharm

Sold $784K (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$784KDisclosed plan

Roland Goette

EVP and President, EMEA

Sold $441K (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$441KNo plan disclosed

Bertram Scott

Director

3.3% · $212KNo plan disclosed

Michael Feld

EVP, Chief Revenue Officer

Sold $171K (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$171KDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Becton Dickinson CEO selling stock?

Yes. Thomas Polen Jr. sold 6.9K shares ($1.2M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Becton Dickinson insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 77% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 23% had no disclosed plan. A trading plan schedules sales in advance.

Are any Becton Dickinson insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Becton Dickinson insiders sell?

About 0.5% overall. As a group they ended with more shares than they started with. These figures leave out Thomas Polen Jr., the largest holder (holdings couldn't be fully reconciled). That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold5 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Thomas Polen Jr. Chairman, CEO and President, Director	$1.2M 6.9K shares	i No percentage: holdings couldn't be fully reconciled.	Disclosed plan
Michael Garrison EVP & Pres Med.Essntl&BioPharm	$784K 4.4K shares	i No percentage: holdings couldn't be fully reconciled.	Disclosed plan
Roland Goette EVP and President, EMEA	$441K 2.4K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed
Bertram Scott Director	$212K 1.2K shares	3.3%	No plan disclosed
Michael Feld EVP, Chief Revenue Officer	$171K 971 shares	i No percentage: holdings couldn't be fully reconciled.	Disclosed plan

The full ownership picture18 of 28 insiders fully reconciled · 28 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Thomas Polen Jr.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +4,692 shares on Jun 1, 2026 (Direct). See the filing Sales and other transactions for Thomas Polen Jr. are complete.

Chairman, CEO and President, Director

n/a

−6.9K

n/a

Vesting, gifts, unvested awards and holding lines for Thomas Polen Jr.

+63Kshares vested or exercised

0gifted (net of own trusts)

−17Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +4,692 shares on Jun 1, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	100,371	110,163
Direct	Rights to Common Stock Under Deferred Compensation Plan	70,855	70,855

Timothy Ring

Minor difference of 196 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

60K

61K

no sales

Vesting, gifts, unvested awards and holding lines for Timothy Ring

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	57,915	59,160
401(k) Plan	Common Stock	2,236	2,285

Additional holdings last reported Jan 24, 2023, not confirmed since: 825 shares. Not included in any total or percentage on this page.

Children, Common Stock: 231 shares, last reported Jan 24, 2023
Direct, Rights to Common Stock Under 1996 Directors Deferral Plan: 594 shares, last reported Feb 15, 2019

Reconciliation: minor difference of 196 shares. Difference is under 0.5% of holdings.

Christopher Jones

Minor difference of 625 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

44K

46K

no sales

Vesting, gifts, unvested awards and holding lines for Christopher Jones

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	22,701	24,304
Direct	Rights to Common Stock Under BD Deferred Compensation Plan	11,089	11,649
Direct	Rights to Common Stock UnderBD Deferred Compensation Plan	9,891	9,891

Additional holdings last reported Nov 11, 2022, not confirmed since: 8,881 shares. Not included in any total or percentage on this page.

Direct, Rights to Common Stock Under 1996 Directors Deferral Plan: 8,881 shares, last reported Nov 11, 2022

Reconciliation: minor difference of 625 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Bertram Scott

Minor difference of 802 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Director

36K

−1.2K

37K

+2%

Vesting, gifts, unvested awards and holding lines for Bertram Scott

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	36,033	36,763

Additional holdings last reported Feb 2, 2021, not confirmed since: 16,138 shares. Not included in any total or percentage on this page.

Direct, Rights to Common Stock Under 1996 Directors Deferral Plan: 16,138 shares, last reported Feb 2, 2021

Reconciliation: minor difference of 802 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Claire Fraser

Includes unvested RSUs, amount not disclosed.

Director

22K

no sales

Vesting, gifts, unvested awards and holding lines for Claire Fraser

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	22,226	22,226

Christopher DelOrefice

Includes unvested RSUs, amount not disclosed.

EVP & Chief Financial Officer

21K

23K

no sales

Vesting, gifts, unvested awards and holding lines for Christopher DelOrefice

0shares vested or exercised

0gifted (net of own trusts)

−4.2Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	21,221	22,982

Roland Goette

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +260 shares on Nov 26, 2025 (GSIP Trust). See the filing Sales and other transactions for Roland Goette are complete.

EVP and President, EMEA

n/a

−2.4K

n/a

Vesting, gifts, unvested awards and holding lines for Roland Goette

0shares vested or exercised

0gifted (net of own trusts)

−138withheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +260 shares on Nov 26, 2025 (GSIP Trust). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	14,217	14,856
GSIP Trust	Common Stock	1,299	1,779

Shana Neal

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +3,786 shares on Apr 6, 2026 (Direct). See the filing Sales and other transactions for Shana Neal are complete.

EVP and Chief People Officer

n/a

Vesting, gifts, unvested awards and holding lines for Shana Neal

0shares vested or exercised

0gifted (net of own trusts)

−3.6Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +3,786 shares on Apr 6, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	13,528	23,966
Direct	Rights to Common Stock Under Deferred Compensation Plan	337	337

Additional holdings last reported Nov 18, 2022, not confirmed since: 1,189 shares. Not included in any total or percentage on this page.

Direct, Deferred Shares of BD stock: 631 shares, last reported Apr 6, 2022
Direct, Rights to Common Stock Under BD Deferred Compensation Plan: 558 shares, last reported Nov 18, 2022

Bilal Muhsin

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +7,201 shares on Jul 1, 2026 (Direct). See the filing Sales and other transactions for Bilal Muhsin are complete.

EVP & President Connected Care

n/a

Vesting, gifts, unvested awards and holding lines for Bilal Muhsin

0shares vested or exercised

0gifted (net of own trusts)

−1.9Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +7,201 shares on Jul 1, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	12,221	41,359

Andrew Eckert

Minor difference of 155 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

9.2K

10K

no sales

Vesting, gifts, unvested awards and holding lines for Andrew Eckert

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	9,170	10,423

Reconciliation: minor difference of 155 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Manish Sinha

Includes unvested RSUs, amount not disclosed. Started reporting during the period; starting holdings are from the Form 3.

EVP and Chief People Officer

8.8K

no sales

Vesting, gifts, unvested awards and holding lines for Manish Sinha

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	8,806	8,806

Michael Feld

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +4,952 shares on Feb 26, 2026 (Direct). See the filing Sales and other transactions for Michael Feld are complete.

EVP, Chief Revenue Officer

n/a

−971

n/a

Vesting, gifts, unvested awards and holding lines for Michael Feld

0shares vested or exercised

0gifted (net of own trusts)

−1.5Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +4,952 shares on Feb 26, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	8,302	19,644

Jeffrey Henderson

Minor difference of 30 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed.

Director

9.2K

no sales

Vesting, gifts, unvested awards and holding lines for Jeffrey Henderson

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	8,015	9,143
Spouse	Common Stock	15	15

Reconciliation: minor difference of 30 shares. Difference is under 0.5% of holdings.

Richard Byrd

Includes unvested RSUs, amount not disclosed.

EVP & President Interventional

6.7K

14K

no sales

Vesting, gifts, unvested awards and holding lines for Richard Byrd

0shares vested or exercised

0gifted (net of own trusts)

−1.7Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	6,736	13,849

Gregory Hayes

Minor difference of 15 shares. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed.

Director

7.2K

no sales

Vesting, gifts, unvested awards and holding lines for Gregory Hayes

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	6,046	7,159

Reconciliation: minor difference of 15 shares. Difference is under 0.5% of holdings.

Carrie Byington

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +1,880 shares on May 8, 2026 (Direct). See the filing Sales and other transactions for Carrie Byington are complete.

Director

n/a

Vesting, gifts, unvested awards and holding lines for Carrie Byington

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +1,880 shares on May 8, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	3,834	5,018
Direct	Rights to Common Stock Under BD Deferred Compensation Plan	1,632	3,810

Additional holdings last reported Nov 11, 2022, not confirmed since: 440 shares. Not included in any total or percentage on this page.

Direct, Rights to Common Stock Under 1996 Directors Deferral Plan: 440 shares, last reported Nov 11, 2022

Michael Garrison

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +3,277 shares on Jun 10, 2026 (Direct). See the filing Sales and other transactions for Michael Garrison are complete.

EVP & Pres Med.Essntl&BioPharm

n/a

−4.4K

n/a

Vesting, gifts, unvested awards and holding lines for Michael Garrison

+3.1Kshares vested or exercised

0gifted (net of own trusts)

−1.8Kwithheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +3,277 shares on Jun 10, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	4,887	13,172

Additional holdings last reported Sep 6, 2022, not confirmed since: 2,997 shares. Not included in any total or percentage on this page.

Direct, Rights to Common Stock Under BD Deferred Compensation Plan: 2,997 shares, last reported Sep 6, 2022

David Shan

Includes unvested RSUs, amount not disclosed.

EVP and Chief ISC Officer

4.6K

8.9K

no sales

Vesting, gifts, unvested awards and holding lines for David Shan

0shares vested or exercised

0gifted (net of own trusts)

−178withheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	4,575	8,926

Vitor Roque

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +1,102 shares on Mar 2, 2026 (Direct). See the filing Sales and other transactions for Vitor Roque are complete.

EVP & Chief Financial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Vitor Roque

0shares vested or exercised

0gifted (net of own trusts)

−190withheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +1,102 shares on Mar 2, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	4,477	8,041

Massimiliano Urbini

Includes unvested RSUs, amount not disclosed. Started reporting during the period; starting holdings are from the Form 3.

EVP & Chief ISC Officer

4.1K

no sales

Vesting, gifts, unvested awards and holding lines for Massimiliano Urbini

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	4,133	4,133

William Brown

Minor difference of 79 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

3.5K

4.7K

no sales

Vesting, gifts, unvested awards and holding lines for William Brown

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	3,486	4,663

Reconciliation: minor difference of 79 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Pavan Mocherla

Includes unvested RSUs, amount not disclosed.

EVP & President, Greater Asia

2.8K

5.8K

no sales

Vesting, gifts, unvested awards and holding lines for Pavan Mocherla

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	2,847	5,763

Joanne Waldstreicher

Minor difference of 23 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends. Includes unvested RSUs, amount not disclosed. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Director

2.3K

3.4K

no sales

Vesting, gifts, unvested awards and holding lines for Joanne Waldstreicher

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	2,270	3,391

Reconciliation: minor difference of 23 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Pamela Spikner

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +560 shares on Mar 2, 2026 (Direct). See the filing Sales and other transactions for Pamela Spikner are complete.

SVP Controller & CAO

n/a

Vesting, gifts, unvested awards and holding lines for Pamela Spikner

0shares vested or exercised

0gifted (net of own trusts)

−84withheld by the company for taxes

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: +560 shares on Mar 2, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	682	3,323

Jacqueline Wright

Minor difference of 1 share. Difference is under 0.5% of holdings. Includes unvested RSUs, amount not disclosed. Started reporting during the period; starting holdings are from the Form 3.

Director

1.3K

no sales

Vesting, gifts, unvested awards and holding lines for Jacqueline Wright

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	0	1,279
Direct	No securities are beneficially owned	0	0

Reconciliation: minor difference of 1 share. Difference is under 0.5% of holdings.

Robert Huffines

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +94 shares on May 8, 2026 (Direct). See the filing Sales and other transactions for Robert Huffines are complete.

Director

n/a

Vesting, gifts, unvested awards and holding lines for Robert Huffines

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Holdings couldn't be fully reconciled. A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +94 shares on May 8, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	1,279
Direct	No securities are beneficially owned	0
Direct	Rights to Common Stock Under BD Deferred Compensation Plan	595

Lanesha Minnix

Includes unvested RSUs, amount not disclosed. Started reporting during the period; starting holdings are from the Form 3.

EVP and General Counsel

7.5K

no sales

Vesting, gifts, unvested awards and holding lines for Lanesha Minnix

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	0	7,492

Peter Menziuso

Includes unvested RSUs, amount not disclosed. Started reporting during the period; starting holdings are from the Form 3.

EVP and President, BDI

14K

no sales

Vesting, gifts, unvested awards and holding lines for Peter Menziuso

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Includes unvested RSUs, amount not disclosed.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct includes unvested RSUs, amount not disclosed	Common Stock	0	14,258

18 of 28 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (9 exactly, 9 with a minor or footnoted difference). For 10 we show sales but not holdings; the ! icon on their rows explains why. Percentages cover 15 of 28 officers and directors. Left out: Thomas Polen Jr., Roland Goette, Shana Neal, Bilal Muhsin, Michael Feld, Carrie Byington, Michael Garrison, Vitor Roque, Pamela Spikner and Robert Huffines (holdings couldn't be fully reconciled); Jacqueline Wright, Lanesha Minnix and Peter Menziuso (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$2.8M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $2.8M across 15,934 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $2.1M · 77%

23%

The lighter segment is sales with no plan disclosed in the filing ($653K), including tax-related sales outside a plan.

No plan disclosed · $653K

Sales with no 10b5-1 plan and no tax reference in the filing. $441K of it is Roland Goette. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Roland Goette, Aug 11, 2026

Taxes

32,747 shares ($0) were withheld by the company for taxes, which isn't a market sale.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Thomas Polen Jr. Chairman, CEO and President, Director	6.9K	$1.2M	100%	42%	Jun 1, 2026 to Aug 13, 2026
Michael Garrison EVP & Pres Med.Essntl&BioPharm	4.4K	$784K	100%	28%	Dec 17, 2025 to Jun 24, 2026
Roland Goette EVP and President, EMEA	2.4K	$441K	0%	16%	Aug 11, 2026 to Aug 11, 2026
Bertram Scott Director	1.2K	$212K	0%	8%	Nov 7, 2025 to Feb 18, 2026
Michael Feld EVP, Chief Revenue Officer	971	$171K	100%	6%	Oct 27, 2025 to Sep 28, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$11K	$11K	$0	$0
Nov 2025	$38K	$0	$0	$38K
Dec 2025	$152K	$152K	$0	$0
Jan 2026	$349K	$349K	$0	$0
Feb 2026	$188K	$14K	$0	$174K
Mar 2026	$12K	$12K	$0	$0
Apr 2026	$11K	$11K	$0	$0
May 2026	$11K	$11K	$0	$0
Jun 2026	$743K	$743K	$0	$0
Jul 2026	$12K	$12K	$0	$0
Aug 2026	$1.2M	$799K	$0	$441K
Sep 2026	$14K	$14K	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 5 insiders sold; the average is 6 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	16K	5	$2.8M
Oct 9, 2025 1 year earlier	21K	8	$4.5M
Oct 9, 2024 2 years earlier	12K	4	$2.9M
Oct 10, 2023 3 years earlier	7K	4	$1.9M
Oct 10, 2022 4 years earlier	54K	7	$14.4M
Oct 10, 2021 5 years earlier	15K	6	$3.7M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty10 insiders whose holdings couldn't be fully reconciled

Thomas Polen Jr.: holdings couldn't be fully reconciled (difference of 4,692 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +4,692 shares on Jun 1, 2026 (Direct). Filing, Jun 1, 2026

Footnote: "The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $145.21 through $147.49. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. | Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-v"

Roland Goette: holdings couldn't be fully reconciled (difference of 552 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +260 shares on Nov 26, 2025 (GSIP Trust). Filing, Nov 26, 2025

Footnote: "Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of November 24, 2025."

Shana Neal: holdings couldn't be fully reconciled (difference of 3,786 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +3,786 shares on Apr 6, 2026 (Direct). Filing, Apr 6, 2026

Footnote: "Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. | Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person."

Bilal Muhsin: holdings couldn't be fully reconciled (difference of 7,201 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +7,201 shares on Jul 1, 2026 (Direct). Filing, Jul 1, 2026

Footnote: "Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. | Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person."

Michael Feld: holdings couldn't be fully reconciled (difference of 4,952 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +4,952 shares on Feb 26, 2026 (Direct). Filing, Feb 26, 2026

Footnote: "Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person."

Carrie Byington: holdings couldn't be fully reconciled (difference of 2,001 shares). A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +1,880 shares on May 8, 2026 (Direct). Filing, May 8, 2026

Footnote: "The securities convert to common stock on a one-for-one basis. | The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. | Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. | Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person."

Michael Garrison: holdings couldn't be fully reconciled (difference of 3,277 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +3,277 shares on Jun 10, 2026 (Direct). Filing, Jun 10, 2026

Footnote: "Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person."

Vitor Roque: holdings couldn't be fully reconciled (difference of 1,102 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +1,102 shares on Mar 2, 2026 (Direct). Filing, Mar 2, 2026

Footnote: "Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person."

Pamela Spikner: holdings couldn't be fully reconciled (difference of 560 shares). Balance changed without a matching transaction, and the footnote does not state the amount: +560 shares on Mar 2, 2026 (Direct). Filing, Mar 2, 2026

Footnote: "Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person."

Robert Huffines: holdings couldn't be fully reconciled (difference of 97 shares). A footnote describes a transfer or distribution between related entities, but the amounts could not be matched to the balance change. Largest: +94 shares on May 8, 2026 (Direct). Filing, May 8, 2026

Footnote: "The securities convert to common stock on a one-for-one basis. | The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. | Includes rights acquired through dividend investment since the last report filed by the reporting person. | Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person."

Timothy Ring: minor difference of 196 shares. Difference is under 0.5% of holdings.

Christopher Jones: minor difference of 625 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Bertram Scott: minor difference of 802 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Andrew Eckert: minor difference of 155 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Jeffrey Henderson: minor difference of 30 shares. Difference is under 0.5% of holdings.

Gregory Hayes: minor difference of 15 shares. Difference is under 0.5% of holdings.

William Brown: minor difference of 79 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Joanne Waldstreicher: minor difference of 23 shares. Unexplained small increases, consistent with stock unit vesting or reinvested dividends.

Jacqueline Wright: minor difference of 1 share. Difference is under 0.5% of holdings.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,898 filings from SEC EDGAR, and how we read them

All 1,898 Forms 3, 4 and 5 filed for Becton Dickinson (SEC CIK 10795) from Jun 3, 2003 to Sep 29, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages. 4 filings were left out because Becton Dickinson filed them as an owner of another company's stock.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (60)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Catherine Burzik	Jan 30, 2025	14,264 shares, last reported balance as of Jan 28, 2025
Michelle Quinn	Dec 3, 2024	7,343 shares, last reported balance as of Nov 26, 2024
Antoine Ezell	Nov 29, 2024	11,970 shares, last reported balance as of Nov 26, 2024
Thomas Spoerel	Jul 2, 2024	2,163 shares, last reported balance as of Jul 1, 2024
David Hickey	Nov 28, 2023	27,281 shares, last reported balance as of Nov 26, 2023
Marshall Larsen	Jan 26, 2023	31,951 shares, last reported balance as of Jan 24, 2023
Samrat Khichi	Jan 5, 2023	9,251 shares, last reported balance as of Dec 21, 2022
Rishi Grover	Jul 12, 2022	9,439 shares, last reported balance as of Jul 8, 2022
James Lim	Jun 24, 2022	24,900 shares, last reported balance as of Jun 17, 2022
Betty Larson	Feb 28, 2022	5,872 shares, last reported balance as of Feb 25, 2022
Simon Campion	Feb 14, 2022	10,319 shares, last reported balance as of Feb 11, 2022
Alexandre Conroy	Feb 7, 2022	23,973 shares, last reported balance as of Feb 3, 2022
David Melcher	Jan 27, 2022	8,444 shares, last reported balance as of Jan 25, 2022
Claire Pomeroy	Jan 26, 2022	9,982 shares, last reported balance as of Jan 25, 2022
Christopher Reidy	Nov 30, 2021	31,524 shares, last reported balance as of Nov 26, 2021
Ribo Mas	Nov 30, 2021	15,324 shares, last reported balance as of Nov 26, 2021
Rebecca Rimel	Sep 8, 2021	11,244 shares, last reported balance as of Sep 8, 2021
Vincent Forlenza	Dec 31, 2020	237,023 shares, last reported balance as of Dec 15, 2020
Patrick Kaltenbach	Nov 30, 2020	10,961 shares, last reported balance as of Nov 26, 2020
Ranjeet Banerjee	Apr 3, 2020	4,571 shares, last reported balance as of Mar 30, 2020
Charles Bodner	Sep 9, 2019	2,119 shares, last reported balance as of Sep 6, 2019
James Borzi	Dec 3, 2018	3,188 shares, last reported balance as of Nov 30, 2018
Wilard Overlock Jr.	Nov 7, 2018	53,271 shares, last reported balance as of Nov 6, 2018
Gary Mecklenburg	Nov 7, 2018	32,722 shares, last reported balance as of Nov 6, 2018
William Tozzi	Jul 11, 2018	19,569 shares, last reported balance as of Jul 2, 2018
Nabil Shabshab	May 14, 2018	7,811 shares, last reported balance as of May 11, 2018
John Gallagher	Mar 6, 2018	1,975 shares, last reported balance as of Mar 2, 2018
Linda Tharby	Feb 14, 2018	15,870 shares, last reported balance as of Feb 1, 2018
John Groetelaars	Jan 4, 2018	42,508 shares, last reported balance as of Jan 2, 2018
Ellen Strahlman	Nov 27, 2017	11,714 shares, last reported balance as of Nov 25, 2017
Gary Cohen	Sep 11, 2017	111,070 shares, last reported balance as of Sep 11, 2017
Stephen Sichak	Sep 11, 2017	14,535 shares, last reported balance as of Sep 8, 2017
Jeffrey Sherman	May 26, 2017	35,266 shares, last reported balance as of May 25, 2017
James Orr	Jan 26, 2017	34,392 shares, last reported balance as of Jan 24, 2017
Basil Anderson	Jan 26, 2017	29,918 shares, last reported balance as of Jan 24, 2017
Jerome Hurwitz	May 9, 2016	3,615 shares, last reported balance as of May 6, 2016
William Kozy	Dec 9, 2015	131,728 shares, last reported balance as of Dec 9, 2015
Henry Becton Jr.	Nov 3, 2015	308,123 shares, last reported balance as of Nov 3, 2015
Edward Degraan	Jan 29, 2015	34,381 shares, last reported balance as of Jan 27, 2015
Joseph Mercurio	Nov 26, 2014	3,636 shares, last reported balance as of Nov 25, 2014
Alfred Sommer	Jan 30, 2014	32,384 shares, last reported balance as of Jan 28, 2014
Donna Boles	May 20, 2013	19,995 shares, last reported balance as of May 17, 2013
Adel Mahmoud	Jan 31, 2013	13,851 shares, last reported balance as of Jan 29, 2013
William Rhodes	Nov 21, 2012	7,289 shares, last reported balance as of Nov 20, 2012
Suketu Upadhyay	Nov 21, 2012	3,568 shares, last reported balance as of Nov 20, 2012
David Elkins	Nov 13, 2012	119 shares, last reported balance as of Dec 2, 2011
Edward Ludwig	Jul 11, 2012	362,311 shares, last reported balance as of Mar 20, 2012
David Durack	Apr 29, 2011	21,211 shares, last reported balance as of Apr 28, 2011
Cathy Minehan	Feb 3, 2011	11,535 shares, last reported balance as of Feb 1, 2011
Patricia Shrader	Nov 24, 2010	22,066 shares, last reported balance as of Nov 20, 2010
Scott Bruder	Nov 24, 2010	7,626 shares, last reported balance as of Nov 5, 2010
John Considine	Nov 25, 2009	208,603 shares, last reported balance as of Nov 21, 2009
Robert Oliynik	Jan 8, 2009	4,879 shares, last reported balance as of Jan 1, 2009
Alfred Hanson	Nov 26, 2008	52,578 shares, last reported balance as of Nov 25, 2008
James Perrella	Nov 2, 2007	41,250 shares, last reported balance as of Oct 31, 2007
Margeretha Ugglas	Feb 2, 2007	28,315 shares, last reported balance as of Jan 31, 2007
Jean Dageville	Dec 9, 2004	9,336 shares, last reported balance as of Dec 8, 2004
Harry Beaty	May 5, 2004	31,739 shares, last reported balance as of May 3, 2004
Frank Olson	Feb 13, 2004	74,098 shares, last reported balance as of Feb 11, 2004
Bridget Healy	Oct 1, 2003	7,347 shares, last reported balance as of Sep 30, 2003

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Becton Dickinson insiders sold $2.8M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Becton Dickinson CEO selling stock?

Why are Becton Dickinson insiders selling?

Are any Becton Dickinson insiders buying?

How much of their stake did Becton Dickinson insiders sell?

The evidence

No plan disclosed · $653K

Taxes

Sales by month